PURLs

It’s time to use an age-based approach to D-dimer

Author and Disclosure Information

 

References

WHAT'S NEW?: We can now make use of the D-dimer in older patients

Up until now, it was acknowledged that the simple and less expensive D-dimer test was less useful for our older patients. In fact, in their 2007 clinical practice guideline on the diagnosis of VTE in primary care, the American Academy of Family Physicians and the American College of Physicians commented on the poor performance of the test in older patients.2 A more recent guideline—released by the Institute for Clinical Systems Improvement in January 2013—provided no specific guidance for patients over age 50.7 The meta-analysis reported on here, however, provides that guidance: Using an age-adjusted D-dimer cutoff improves the diagnostic accuracy of D-dimer screening in older adults.

CAVEATS: Results are not generalizable to patients at higher risk

These findings are not generalizable to all patients, particularly those at higher clinical risk who would undergo imaging regardless of D-dimer results. Not all patients included in this meta-analysis whose D-dimer was negative received imaging to confirm that they did not have VTE. As a result, the diagnostic accuracy of using an age-adjusted cutoff could have been overestimated, although this is likely not clinically important because these cases would have remained symptomatic within the 45-day to 3-month follow-up period.

CHALLENGES TO IMPLEMENTATION: You, not the lab, will need to do the calculation

One of the more valuable aspects of this study is it identifies a simple calculation that can directly improve patient care. Physicians can easily apply an age-adjusted D-dimer cutoff as they interpret lab results by multiplying the patient’s age in years × 10 mcg/L. While this does not require institutional changes by the lab, hospital, or clinic, it would be helpful if the age-adjusted D-dimer calculation was provided with the lab results.

Acknowledgement

The PURLs Surveillance System was supported in part by Grant Number UL1RR024999 from the National Center for Research Resources, a Clinical Translational Science Award to the University of Chicago. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health.

Pages

Copyright © 2014 Family Physicians Inquiries Network. All rights reserved.

Online-Only Materials

AttachmentSize
File JFP06303155_methodology51.55 KB

Recommended Reading

Latest heart failure guidelines break new ground
MDedge Family Medicine
FDA approves droxidopa for neurogenic orthostatic hypotension
MDedge Family Medicine
Medicare to cover cardiac rehab for some HF patients
MDedge Family Medicine
VIDEO: Device detects more atrial fibrillation, but when is intervention necessary?
MDedge Family Medicine
Continuous AF monitors raise questions about when to intervene
MDedge Family Medicine
USPSTF: Insufficient evidence to judge vitamin supplements
MDedge Family Medicine
AAN issues nonvalvular atrial fibrillation stroke prevention guideline
MDedge Family Medicine
Obesity prevalence steady between 2003 and 2012
MDedge Family Medicine
TNF inhibitors reduce coronary artery disease risk in rheumatoid arthritis
MDedge Family Medicine
Physician/patient communication on ICDs deemed problematic
MDedge Family Medicine